Clinical Trial Update: Pharmacokinetic Study With a Loading Dose of Clofazimine in Adult Patients With Nontuberculous Mycobacterial Disease [Phase 2]

View source ↗

Summary

A Phase 2 pharmacokinetic study of a loading dose of clofazimine in adults with nontuberculous mycobacterial disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nontuberculous Mycobacterial Diseases

Drugs mentioned

• Clofazimine (clofazimine)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Nontuberculous Mycobacterial Diseases | Phase 2 | Status: COMPLETED